TY - JOUR
AU - Lechan, Ronald, M.
AB - The nonthyroidal illness syndrome associated with fasting, infection, and chronic illness is characterized by low thyroid hormone levels and low or inappropriately normal TSH levels in circulating blood and reduced synthesis of TRH in hypophysiotropic neurons residing in the hypothalamic paraventricular nucleus (PVN). To test the hypothesis that ascending brainstem pathways are involved in mediation of bacterial lipopolysaccharide (LPS)-induced suppression of TRH mRNA in the PVN, we unilaterally transected brainstem pathways to the PVN and determined the effects of LPS on TRH gene expression and, as a control, on CRH gene expression in hypophysiotropic neurons using semiquantitative in situ hybridization histochemistry. The efficacy of the transection was determined by immunocytochemical detection of ascending adrenergic pathways in the PVN. In vehicle-treated animals, CRH mRNA in the PVN showed a significant reduction on the transected side compared with the intact side, whereas a significant increase in TRH mRNA was observed on the transected side compared with the intact side. After LPS administration (250 μg/100 g body weight), a dramatic increase in CRH mRNA was observed on the intact side, and a significantly lesser increase was found on the transected side. In contrast, LPS treatment resulted in reduction in TRH mRNA on the transected side compared with the intact side and a significant reduction in TRH mRNA on the transected side compared with vehicle-treated animals. These studies confirm an important role of ascending brainstem projections in LPS-induced activation of CRH gene expression, but indicate that they do not mediate the effect of LPS to inhibit hypophysiotropic TRH gene expression. FASTING IS ASSOCIATED with inhibition of the hypothalamic-pituitary-thyroid (HPT) axis, largely due to the reduction in circulating levels of leptin (1, 2). Leptin acts primarily on two distinct populations of neurons in the arcuate nucleus that inversely regulate TRH gene expression in hypophysiotropic neurons of the hypothalamic paraventricular nucleus (PVN): α-MSH-producing neurons that coexpress cocaine- and amphetamine-regulated transcript (CART), and neuropeptide Y (NPY)-producing neurons that coexpress agouti gene-related protein (AGRP) (see review in Ref.3). Thus, during fasting, the expression of proopiomelanocortin (POMC), a precursor protein of α-MSH, and CART are reduced, whereas there is a marked increase in the genes encoding NPY and AGRP (4, 5). Both NPY and AGRP have a potent inhibitory effect on TRH mRNA in the PVN and result in a substantial reduction in TSH and circulating thyroid hormone levels (6). Conversely, α-MSH and CART have potent activating effects and can prevent the fasting-induced reduction in TRH mRNA when given exogenously (7, 8). Although the suppression of POMC and CART gene expression and the up-regulation of NPY and AGRP gene expression contribute to fasting-induced inhibition of the HPT axis, this mechanism does not appear to participate in inhibiting the HPT axis during infection (3). After the administration of bacterial endotoxin, there is an increase in circulating levels of leptin (9) and increased POMC (10, 11) and CART gene expression (11), but no significant change in NPY gene expression in the arcuate nucleus (11). Nevertheless, the HPT axis and, in particular, TRH mRNA in the PVN is suppressed (12), suggesting that a different set of regulatory controls over hypophysiotropic TRH neurons from that observed during fasting occurs after the administration of endotoxin, overriding the activating effects of increased leptin, α-MSH, and CART on the HPT axis. The PVN receives strong input from autonomic centers in the lower brainstem, including the nucleus tractus solitarius, dorsal motor nucleus of the vagus, and several catecholamine groups in the dorsal and ventrolateral medulla (13–15). These brainstem nuclei are known to be influenced by endotoxin administration (16, 17) and are involved in the activation of hypophysiotropic CRH-synthesizing neurons of the PVN (18, 19). Because hypophysiotropic TRH neurons receive strong input from brainstem catecholamine-producing neurons (20, 21), we hypothesized that ascending brainstem pathways may mediate the inhibitory effects of endotoxin on the HPT axis. Therefore, we unilaterally transected the ascending brainstem pathways in the posterior hypothalamus and determined whether the lack of brainstem inputs alters the effect of bacterial lipopolysaccharide (LPS) on TRH gene expression in hypophysiotropic neurons. Materials and Methods Animals and tissue preparation The experiments were performed on adult male Sprague Dawley rats (Taconic Farms, Germantown, NY), weighing 210–230 g. The animals were housed in cages under standard environmental conditions (lights on between 0600–1800 h; temperature, 22 ± 1 C; rat chow and water ad libitum). All experimental protocols were reviewed and approved by the institutional animal care and use committee at Tufts-New England Medical Center and Tufts University School of Medicine. Rats were deeply anesthetized with sodium pentobarbital (35 mg/kg body weight, ip), and under stereotaxic guidance using a stereotaxic apparatus (Cartesian Research, Inc., Sandy, OR), a 3-mm-wide glass knife was lowered into the brain at the level of the posterior hypothalamus parallel with the coronal plane. The coordinates of the medial edge of knife were; anterior-posterior, −4.0 mm from the bregma; lateral, 0 mm; and dorsoventral, −9.0 from the surface of the skull. After 2 wk of survival, the animals were divided into two groups. The first group (n = 9) received an ip injection of sterile saline, whereas animals in the second group (n = 9) received an equal volume of bacterial LPS (Sigma-Aldrich Corp., St. Louis, MO; 0127:B8; 250 μg/100 g body weight, ip, in sterile saline). All injections were given between 0900–1200 h. The rectal temperature of the rats was measured by a digital thermometer before and 2, 4, 6, and 24 h after the injection. The animals were weighed before the injection and before being euthanized. Twenty-four hours after the injections, when TRH mRNA is significantly decreased by LPS (12), the animals were overdosed with pentobarbital and perfused transcardially with 20 ml 0.01 m PBS, pH 7.4, containing 15,000 U/liter heparin sulfate, followed by 150 ml 4% paraformaldehyde in 0.1 m phosphate buffer (PB; pH 7.4). After perfusion, the brains were postfixed by immersion in 4% paraformaldehyde in 0.1 m PB (pH 7.4) for 4 h at room temperature. The hypothalamic blocks were transferred into 20% sucrose in 0.01 m PBS at 4 C overnight to promote cryoprotection. Serial 18-μm-thick coronal sections through the rostrocaudal extent of the PVN were cut on a cryostat (CM3050 S, Leica Microsystems, Nussloch, Germany) and adhered to SuperFrost Plus glass slides (Fisher Scientific Co., Pittsburgh, PA) or collected in glass vials containing PBS (pH 7.4) and stored in freezing solution (30% ethylene glycol, 25% glycerol, 0.05 m PB) at −20 C until used. Three sets of sections containing every fourth section through the PVN were mounted, and one set was stored in freezing solution. Mounted tissue sections were desiccated overnight at 42 C and stored at −80 C until prepared for in situ hybridization histochemistry. Immunohistochemical detection of phenylethanolamine N-methyltransferase (PNMT)-containing fibers in the PVN To assess the efficacy of the knife cut, PNMT immunocytochemistry was performed on free-floating sections. Briefly, the sections were treated in 0.5% H2O2 for 15 min to block endogenous peroxidase activity, followed by 0.5% Triton X-100 in PBS for 1 h to improve antibody penetration, and then in 10% normal horse serum in PBS for 30–40 min to reduce nonspecific antibody binding. The sections were incubated in sheep antisera to PNMT (Chemicon International, Temecula, CA) at a 1:5000 dilution in 1% normal horse serum in PBS containing 0.08% sodium azide and 0.2% Kodak Photo Flo (Eastman Kodak Co., Rochester, NY) for 2 d at 4 C. After thorough rinsing in PBS, the sections were incubated in rabbit antisheep IgG (1:200; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA) for 2 h at room temperature. The sections were then immersed in avidin-peroxidase complex (1:100; ABC Elite Kit, Vector Laboratories, Inc., Burlingame, CA) for 1 h. The immunoreaction was developed in 0.025% diaminobenzidine containing 0.03% H2O2 in Tris buffer (pH 7.6) for 3–5 min to yield brown labeling. A rinse in Tris buffer (pH 7.6) was used to stop the reaction. PNMT-labeled sections were then mounted onto glass slides, dehydrated in a graded series of ethanol, followed by three changes in Histosol, and then coverslipped in DPX mountant (Sigma-Aldrich Corp.) for light microscopy. In situ hybridization histochemistry Every fourth section through the hypothalamus from the region of the PVN was subjected to in situ hybridization histochemistry as previously described (22), using a single-stranded, [35S]UTP-labeled cRNA probe for CRH generated from a 976-bp cDNA (23) or TRH generated from a 1241-bp EcoRI-PstI fragment of pro-TRH cDNA (24), respectively. Hybridization was performed under plastic coverslips in buffer containing 50% formamide, a 2-fold concentration of standard sodium citrate, 10% dextran sulfate, 0.255% BSA, 0.25% Ficoll 400, 0.25% polyvinyl pyrollidine 360, 250 mm Tris (pH 7.5), 0.5% sodium pyrophosphate, 0.5% sodium dodecyl sulfate, 250 μg/ml denatured salmon sperm DNA, and 6 × 105 cpm radiolabeled probes for 16 h at 55 C. Slides were washed in graded solutions in ethanol containing 0.3 m ammonium acetate, and dipped into Kodak NTB2 photographic emulsion (Eastman Kodak Co.). Autoradiographs were developed after exposure for 2–4 d. Specificity of hybridization for both CRH and TRH mRNA in the PVN has been described previously (24, 25). Image analysis To study the effects of the knife cut on the PNMT-immunoreactive innervation of the PVN, sections were analyzed under darkfield microscopy, and density values of the PNMT innervation exclusive to each side of the PVN for each animal were measured. The images were captured using a COHU 4910 video camera (COHU, Inc., San Diego, CA) and a color PCI frame grabber board (Scion Corp., Frederick, MD) and were analyzed with a Macintosh G4 computer (Apple Computer, Redmond, WA) using Scion Image software. Background density points were removed by thresholding the image, and integrated density values (density × area) of PNMT-immunoreactive axons in the same region on each side of the PVN were measured for each animal. In situ hybridization autoradiograms were similarly analyzed. Background density points were removed by thresholding the image, and integrated density values (density × area) of hybridized neurons in the same region of the PVN were measured in three (CRH) or five (TRH) consecutive sections for each animal in both the intact and transected sides. The sum of the integrated density units were calculated for each animal. Nonlinearity of radioactivity in the emulsion was evaluated by comparing density values with a calibration curve created from autoradiograms of known dilutions of the radiolabeled probes, immobilized on glass slides in 1.5% gelatin, fixed with 4% formaldehyde, and exposed and developed simultaneously with the in situ hybridization autoradiograms. Statistical analysis Analyses used the natural logs of density of both CRH and TRH mRNA because of the skewness and lack of homogeneity of variance of the data. Paired t tests were used for comparing the intact and tran-sected sides of individual animals, whereas two-sample t tests were used to compare the effects of treating animals with either LPS or vehicle in terms of the density ratios. Temperature data were analyzed using nested ANOVA, and the change in weight was analyzed by t tests. A significance level of P < 0.05 was considered statistically significant. All analyses were run with SPSS version 11 (SPSS, Inc., Chicago, IL). Data are presented as the mean ± sem. Results Efficacy of the transection of the ascending brainstem pathways An intense network of PNMT fibers was observed within the PVN on the intact side, whereas animals with successful transection of the ascending brainstem pathways showed a marked reduction in PNMT immunoreactivity on the tran-sected side (Fig. 1). Of 18 animals, 14 that had greater than 59% reduction in PNMT fiber density on the transected side of the PVN (range, 59.6–85.6%; mean for vehicle-treated animals, 73.0 ± 3.5%; mean for LPS-treated animals, 74.5 ± 2.2%) were selected for additional study. Fig. 1. Open in new tabDownload slide Dark-field photomicrographs of coronal sections through the hypothalamic PVN immunolabeled with antisera to PNMT. Transection of the ascending brainstem pathways to the PVN has been performed on one side of the PVN. Note the marked reduction in PNMT immunoreactivity in axon terminals innervating the PVN on the transected side compared with that on the intact side. III, Third ventricle. Scale bar, 100 μm. Fig. 1. Open in new tabDownload slide Dark-field photomicrographs of coronal sections through the hypothalamic PVN immunolabeled with antisera to PNMT. Transection of the ascending brainstem pathways to the PVN has been performed on one side of the PVN. Note the marked reduction in PNMT immunoreactivity in axon terminals innervating the PVN on the transected side compared with that on the intact side. III, Third ventricle. Scale bar, 100 μm. Effects of LPS administration on temperature and body weight Table 1 shows the changes in rectal temperature over the course of the experiment. Nested ANOVA showed a significant interaction between treatment and time (P < 0.001). The temperature of control rats was stable during the entire experiment compared with LPS administration, which resulted in an early reduction in temperature 2 h after the injection, followed by a temperature rise 6 and 24 h postinjection. The control group behaved differently from the LPS-treated animals; they had an insignificant weight gain (1.0 ± 1.4 g) at the termination of the experiment, whereas the LPS-treated group lost weight (−29.7 ± 5.7 g; P < 0.001). TABLE 1. Rectal temperature after LPS administration 0 h 2 h 4 h 6 h 24 h Controls (n = 7) 37.69 ± 0.07 37.65 ± 0.08 37.58 ± 0.09 37.69 ± 0.09 37.40 ± 0.1 LPS-treated (n = 7) 37.45 ± 0.09 36.39 ± 0.24 37.58 ± 0.20 38.24 ± 0.26 38.67 ± 0.19 0 h 2 h 4 h 6 h 24 h Controls (n = 7) 37.69 ± 0.07 37.65 ± 0.08 37.58 ± 0.09 37.69 ± 0.09 37.40 ± 0.1 LPS-treated (n = 7) 37.45 ± 0.09 36.39 ± 0.24 37.58 ± 0.20 38.24 ± 0.26 38.67 ± 0.19 ANOVA shows that the controls and treated animals behave differently with time (P < 0.001). Open in new tab TABLE 1. Rectal temperature after LPS administration 0 h 2 h 4 h 6 h 24 h Controls (n = 7) 37.69 ± 0.07 37.65 ± 0.08 37.58 ± 0.09 37.69 ± 0.09 37.40 ± 0.1 LPS-treated (n = 7) 37.45 ± 0.09 36.39 ± 0.24 37.58 ± 0.20 38.24 ± 0.26 38.67 ± 0.19 0 h 2 h 4 h 6 h 24 h Controls (n = 7) 37.69 ± 0.07 37.65 ± 0.08 37.58 ± 0.09 37.69 ± 0.09 37.40 ± 0.1 LPS-treated (n = 7) 37.45 ± 0.09 36.39 ± 0.24 37.58 ± 0.20 38.24 ± 0.26 38.67 ± 0.19 ANOVA shows that the controls and treated animals behave differently with time (P < 0.001). Open in new tab Effect of unilateral transection of ascending brainstem pathways on CRH and TRH mRNA in the PVN CRH and TRH mRNA were readily visualized in the PVN by in situ hybridization histochemistry (Figs. 2A and 3A). Neurons containing CRH mRNA were more laterally located in the medial parvocellular subdivision compared with neurons containing TRH mRNA. In addition, only the latter group extended into the periventricular parvocellular subdivision of the PVN and concentrated in a cluster of densely packed neurons in the caudal aspects of the medial parvocellular subdivision. Fig. 2. Open in new tabDownload slide Dark-field photomicrographs of CRH mRNA in coronal sections of the hypothalamic PVN in animals with transection of ascending brainstem pathways on one side of the hypothalamus after an ip injection of vehicle (A) or bacterial LPS (B). The LPS-induced increase in CRH mRNA is significantly reduced on the transected side. C, Mean of the log integrated density units of CRH mRNA in the PVN of vehicle- and LPS-treated animals by computerized image analysis. III, Third ventricle. Scale bar, 100 μm. *, P < 0.001 compared with intact side control; #, P < 0.001 compared with transected side control and intact side LPS. Fig. 2. Open in new tabDownload slide Dark-field photomicrographs of CRH mRNA in coronal sections of the hypothalamic PVN in animals with transection of ascending brainstem pathways on one side of the hypothalamus after an ip injection of vehicle (A) or bacterial LPS (B). The LPS-induced increase in CRH mRNA is significantly reduced on the transected side. C, Mean of the log integrated density units of CRH mRNA in the PVN of vehicle- and LPS-treated animals by computerized image analysis. III, Third ventricle. Scale bar, 100 μm. *, P < 0.001 compared with intact side control; #, P < 0.001 compared with transected side control and intact side LPS. Fig. 3. Open in new tabDownload slide Dark-field photomicrographs of TRH mRNA in coronal sections through the hypothalamic PVN in animals with transection of ascending brainstem pathways on one side of the hypothalamus after ip injection of vehicle (A) or bacterial LPS (B). Note the increase in TRH mRNA in the PVN on the transected side compared with the intact side in vehicle-treated controls. After LPS administration, TRH mRNA is significantly reduced on the transected side compared with the intact side and the transected side of vehicle-treated controls. C, Mean of the log integrated density units of TRH mRNA in the PVN of vehicle- and LPS-treated animals by computerized image analysis. III, Third ventricle. Scale bar, 100 μm. *, P = 0.006 compared with intact side of vehicle controls; #, P = 0.005 compared with transected side of vehicle controls. Fig. 3. Open in new tabDownload slide Dark-field photomicrographs of TRH mRNA in coronal sections through the hypothalamic PVN in animals with transection of ascending brainstem pathways on one side of the hypothalamus after ip injection of vehicle (A) or bacterial LPS (B). Note the increase in TRH mRNA in the PVN on the transected side compared with the intact side in vehicle-treated controls. After LPS administration, TRH mRNA is significantly reduced on the transected side compared with the intact side and the transected side of vehicle-treated controls. C, Mean of the log integrated density units of TRH mRNA in the PVN of vehicle- and LPS-treated animals by computerized image analysis. III, Third ventricle. Scale bar, 100 μm. *, P = 0.006 compared with intact side of vehicle controls; #, P = 0.005 compared with transected side of vehicle controls. In vehicle-treated animals, transection resulted in a significant reduction of silver grains denoting CRH mRNA in the PVN (Fig. 2A), whereas TRH mRNA was significantly increased on the side of transection (Fig. 3A). By image analysis, mean log integrated density units of CRH mRNA on the intact vs. transected sides were 1.84 ± 0.14 vs. 1.39 ± 0.13 (P < 0.001), respectively, and for TRH mRNA, were 3.78 ± 0.56 vs. 4.36 ± 0.57 (P = 0.006; Figs. 2C and 3C). Effect of LPS treatment on CRH and TRH mRNA expression in the PVN LPS resulted in nearly a 400% increase in the accumulation of silver grains over hybridized CRH neurons in the PVN on the intact side compared with that in vehicle-treated controls (P < 0.001; compare Fig. 2, A vs. B). LPS also increased CRH mRNA on the transected side, but the increase was significantly less than that on the intact side (intact vs. transected, mean log integrated density units, 6.88 ± 0.91 vs. 4.03 ± 0.33; P < 0.001; Fig. 2C). In contrast, although there was a tendency for LPS treatment to result in a reduction in TRH mRNA in the PVN on the intact side compared with that in vehicle-treated controls (Fig. 3C), by image analysis the difference was not significant (Table 2). TRH mRNA in LPS-treated animals on the transected side also showed a reduction compared with that in vehicle-treated controls (Fig. 3, A and B), which by image analysis was significant (vehicle tran-sected vs. LPS transected, mean log integrated density units, 4.36 ± 0.57 vs. 2.16 ± 0.39; P < 0.005). In addition, a significant reduction in TRH mRNA was observed in LPS-treated animals on the transected side compared with the intact side (LPS intact vs. LPS transected, mean log integrated density units, 2.65 ± 0.51 vs. 2.16 ± 0.39; P = 0.002). TABLE 2. Summary of mean log integrated density units and statistical analyses of CRH mRNA and TRH mRNA on transected and intact sides of the PVN after vehicle or LPS administration CRH mRNA (log integrated density units) TRH mRNA (log integrated density units) Transected Intact Ratio transected/ intact Transected vs. intact (P value) Transected Intact Ratio transected/ intact Transected vs. intact (P value) Vehicle (n = 7) 1.39 ± 0.13 1.84 ± 0.14 0.76 ± 0.040 (<0.001) 4.36 ± 0.57 3.78 ± 0.56 1.21 ± 0.029 (0.006) LPS (n = 7) 4.03 ± 0.33 6.88 ± 0.91 0.61 ± 0.038 (<0.001) 2.16 ± 0.39 2.65 ± 0.51 0.86 ± 0.033 (0.002) LPS vs. vehicle (P value) <0.001 <0.001 0.024 0.005 0.13 <0.001 CRH mRNA (log integrated density units) TRH mRNA (log integrated density units) Transected Intact Ratio transected/ intact Transected vs. intact (P value) Transected Intact Ratio transected/ intact Transected vs. intact (P value) Vehicle (n = 7) 1.39 ± 0.13 1.84 ± 0.14 0.76 ± 0.040 (<0.001) 4.36 ± 0.57 3.78 ± 0.56 1.21 ± 0.029 (0.006) LPS (n = 7) 4.03 ± 0.33 6.88 ± 0.91 0.61 ± 0.038 (<0.001) 2.16 ± 0.39 2.65 ± 0.51 0.86 ± 0.033 (0.002) LPS vs. vehicle (P value) <0.001 <0.001 0.024 0.005 0.13 <0.001 Open in new tab TABLE 2. Summary of mean log integrated density units and statistical analyses of CRH mRNA and TRH mRNA on transected and intact sides of the PVN after vehicle or LPS administration CRH mRNA (log integrated density units) TRH mRNA (log integrated density units) Transected Intact Ratio transected/ intact Transected vs. intact (P value) Transected Intact Ratio transected/ intact Transected vs. intact (P value) Vehicle (n = 7) 1.39 ± 0.13 1.84 ± 0.14 0.76 ± 0.040 (<0.001) 4.36 ± 0.57 3.78 ± 0.56 1.21 ± 0.029 (0.006) LPS (n = 7) 4.03 ± 0.33 6.88 ± 0.91 0.61 ± 0.038 (<0.001) 2.16 ± 0.39 2.65 ± 0.51 0.86 ± 0.033 (0.002) LPS vs. vehicle (P value) <0.001 <0.001 0.024 0.005 0.13 <0.001 CRH mRNA (log integrated density units) TRH mRNA (log integrated density units) Transected Intact Ratio transected/ intact Transected vs. intact (P value) Transected Intact Ratio transected/ intact Transected vs. intact (P value) Vehicle (n = 7) 1.39 ± 0.13 1.84 ± 0.14 0.76 ± 0.040 (<0.001) 4.36 ± 0.57 3.78 ± 0.56 1.21 ± 0.029 (0.006) LPS (n = 7) 4.03 ± 0.33 6.88 ± 0.91 0.61 ± 0.038 (<0.001) 2.16 ± 0.39 2.65 ± 0.51 0.86 ± 0.033 (0.002) LPS vs. vehicle (P value) <0.001 <0.001 0.024 0.005 0.13 <0.001 Open in new tab A summary of the mean log density units and their ratios for CRH and TRH mRNA for each treatment group is shown in Table 2. This table also shows the results of the primary analyses comparing intact and transected sides in both vehicle- and LPS-treated animals, and additionally, the magnitude and direction of the differences between the two treatment groups. Discussion Bacterial infection results in a number of alterations in central regulation of the neuroendocrine axis, including activation of the hypothalamic-pituitary-adrenal axis and inhibition of the HPT axis (26). Because previous data demonstrated that brainstem pathways play a pivotal role in the activation of hypophysiotropic CRH neurons by LPS (18), we hypothesized that these pathways may also be important in mediating the effects of LPS on the thyroid axis via regulation of hypophysiotropic TRH neurons. To test the hypothesis, we studied the effect of LPS on TRH mRNA levels in hypophysiotropic neurons after unilateral transection of the ascending brainstem pathways that project to the PVN. In vehicle-treated animals, transection of the ascending brainstem pathways to the PVN resulted in a significant reduction in CRH mRNA on the ipsilateral side, consistent with the role of catecholamines to increase CRH secretion (27). These pathways also carry axons containing CART and glucagon like peptide-1 (15, 28), however, that are known to activate the hypothalamic-pituitary-adrenal axis through central effects on CRH neurons (29, 30). Thus, the effect of the transection to diminish the stimulatory action of these peptides in the PVN may have also contributed to the reduction in CRH mRNA on that side. In contrast to the effects of transection on CRH mRNA, TRH mRNA in the PVN was significantly increased on the transected side, suggesting that contrary to the regulation of hypophysiotropic CRH neurons, under basal conditions the ascending brainstem projections to hypophysiotropic TRH neurons exert a net inhibitory effect. Although the nature of this inhibitory input is yet unknown, the fact that NPY exerts a potent inhibitory effect on the HPT axis when administered intracerebroventricularly (22) and is co-contained in a subset of the catecholamine fiber projection to TRH neurons in the PVN (31), raise the possibility that NPY may contribute to this inhibitory tone. Alternatively, given the evidence for innervation of TRH neurons by CRH-containing fibers (32), and that CRH is capable of inhibiting TRH release from hypothalamic cultures (33), the reduction in CRH gene expression on the side of the knife cut may have contributed to the increase in TRH gene expression on the transected side of the brain. After systemic administration of LPS, a dramatic increase in CRH mRNA was observed on the intact side of the PVN, similar to earlier observations (18, 25). The absence of the ascending brainstem projections to the PVN on the side of the knife cut substantially reduced the effects of LPS administration on CRH gene expression in the PVN, consistent with previous studies by Ericsson et al. (18). Together with the significant reduction of the adrenergic fibers on the side of transection, these data substantiate that transection of projection pathways from the medulla to the PVN was adequate to prevent LPS from exerting maximal effects on hypophysiotropic CRH neurons. Therefore, were LPS to mediate its inhibitory effects on hypophysiotropic TRH gene expression in the PVN via ascending brainstem pathways, we would have anticipated an increase in TRH mRNA in the tran-sected side of the PVN after LPS administration. This is based on the observation that endotoxin increases circulating levels of leptin (9), CART mRNA in the arcuate nucleus (11), and melanocortin signaling in the PVN (10), whereas it does not increase NPY expression in the arcuate nucleus (11). Each of these alterations would have been expected to activate TRH gene expression in hypophysiotropic neurons rather than result in suppression as observed. Thus, removing an overriding inhibitory effect of the brainstem projections on hypophysiotropic TRH should have allowed the activating effects of each of the above factors induced by LPS to exert its effects on TRH mRNA unopposed. Nevertheless, LPS reduced TRH mRNA on the transected side of PVN compared with vehicle-treated controls, indicating that the ascending brainstem projections to hypophysiotropic TRH neurons do not mediate the inhibitory effects of LPS on the HPT axis. Presumably, therefore, other mechanisms must be operable. Indeed, the observation that the inhibitory effect of LPS on TRH mRNA in the PVN was greater on the transected than the intact side would indicate that under these circumstances, the net effect of brainstem projections to TRH neurons is stimulatory. This activating effect by LPS may be mediated by an increase in the release of catecholamines (34) similar to that observed for CRH and/or by CART, which is coproduced in adrenergic neurons (15, 35). Although the mechanism by which LPS inhibits the HPT axis remains unknown, we have observed that immune activation increases type 2 iodothyronine deiodinase (D2) mRNA and D2 enzymatic activity in the mediobasal hypothalamus of the rat (36), recently confirmed by Boelen et al. (37) in mice. This increase in D2 activity in the mediobasal hypothalamus occurs primarily in specialized ependymal cells called tanycytes, which are located in the base and infralateral walls of the third ventricle. These cells extend cytoplasmic processes through the substance of the median eminence to terminate on the portal capillary plexus, creating a cytoplasmic conduit interconnecting the cerebrospinal fluid and vascular compartments (38, 39). Because these cells are the main source of T3 production in the hypothalamus, we have proposed that endotoxin may result in tissue-specific, D2-mediated thyrotoxicosis in the mediobasal hypothalamus (9). The increase in the local T3 level may then suppress the synthesis of TRH in hypophysiotropic neurons either by local feedback inhibition through the release of T3 from tanycyte apical processes into the cerebrospinal fluid or by uptake from hypophysiotropic TRH axonal processes in the median eminence and retrograde transport to the hypothalamic PVN (9). Although it could be hypothesized that elevated corticosterone levels have a direct inhibitory effect on hypophysiotropic TRH neurons (40), studies by Kondo et al. (12) have shown that adrenalectomized animals replaced with corticosterone to simulate normal circulating levels shows similar responses of the HPT axis to LPS as intact controls. In summary, transection of ascending pathways from the brainstem to the PVN does not prevent LPS from inhibiting TRH gene expression in hypophysiotropic neurons and may even accentuate the inhibitory response. We conclude, therefore, that LPS must exert other regulatory mechanisms over hypophysiotropic TRH neurons that contribute to inhibition of the HPT axis. This work was supported by grants from the National Institutes of Health (DK-37021) and the Hungarian Science Foundation (OTKA T046492). Abbreviations AGRP, Agouti gene-related protein; CART, cocaine- and amphetamine-regulated transcript; D2, type 2 iodothyronine deiodinase; HPT, hypothalamic-pituitary-thyroid; LPS, lipopolysaccharide; NPY, neuropeptide Y; PB, phosphate buffer; PNMT, phenylethanolamine N-methyltransferase; POMC, proopiomelanocortin; PVN, paraventricular nucleus. References 1 Ahima RS , Prabakaran D , Mantzoros C , Qu D , Lowell B , Maratos-Flier E , Flier JS 1996 Role of leptin in the neuroendocrine response to fasting. Nature 382 : 250 – 252 Google Scholar Crossref Search ADS PubMed WorldCat 2 Légrádi G , Emerson CH , Ahima RS , Flier JS , Lechan RM 1997 Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 138 : 2569 – 2576 Google Scholar PubMed WorldCat 3 Lechan RM , Fekete C 2004 Feedback regulation of thyrotropin-releasing hormone (TRH): mechanisms for the non-thyroidal illness syndrome . J Endocrinol Invest 27 (Suppl) : 105 – 119 Google Scholar PubMed WorldCat 4 Ahima RS , Kelly J , Elmquist JK , Flier JS 1999 Distinct physiologic and neuronal responses to decreased leptin and mild hyperleptinemia. Endocrinology 140 : 4923 – 4931 Google Scholar PubMed WorldCat 5 Hahn TM , Breininger JF , Baskin DG , Schwartz MW 1998 Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat Neurosci 1 : 271 – 272 Google Scholar Crossref Search ADS PubMed WorldCat 6 Fekete C , Sarkar S , Rand WM , Harney JW , Emerson CH , Bianco AC , Lechan RM 2002 Agouti-related protein (AGRP) has a central inhibitory action on the hypothalamic-pituitary-thyroid (HPT) axis; comparisons between the effect of AGRP and neuropeptide Y on energy homeostasis and the HPT axis. Endocrinology 143 : 3846 – 3853 Google Scholar Crossref Search ADS PubMed WorldCat 7 Fekete C , Légrádi G , Mihály E , Huang QH , Tatro JB , Rand WM , Emerson CH , Lechan RM 2000 α-Melanocyte-stimulating hormone is contained in nerve terminals innervating thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and prevents fasting-induced suppression of prothyrotropin-releasing hormone gene expression. J Neurosci 20 : 1550 – 1558 Google Scholar PubMed WorldCat 8 Fekete C , Mihály E , Luo LG , Kelly J , Clausen JT , Mao Q , Rand WM , Moss LG , Kuhar M , Emerson CH , Jackson IMD , Lechan RM 2000 Association of cocaine- and amphetamine-regulated transcript-immunoreactive elements with thyrotropin-releasing hormone-synthesizing neurons in the hypothalamic paraventricular nucleus and its role in the regulation of the hypothalamic-pituitary-thyroid axis during fasting. J Neurosci 20 : 9224 – 9234 Google Scholar PubMed WorldCat 9 Grunfeld C , Zhao C , Fuller J , Pollack A , Moser A , Friedman J , Feingold KR 1996 Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest 97 : 2152 – 2157 Google Scholar Crossref Search ADS PubMed WorldCat 10 Marks DL , Cone RD 2001 Central melanocortins and the regulation of weight during acute and chronic disease. Recent Prog Horm Res 56 : 359 – 375 Google Scholar Crossref Search ADS PubMed WorldCat 11 Sergeyev V , Broberger C , Hokfelt T 2001 Effect of LPS administration on the expression of POMC, NPY, galanin, CART and MCH mRNAs in the rat hypothalamus. Brain Res Mol Brain Res 90 : 93 – 100 Google Scholar Crossref Search ADS PubMed WorldCat 12 Kondo K , Harbuz MS , Levy A , Lightman SL 1997 Inhibition of the hypothalamic-pituitary-thyroid axis in response to lipopolysaccharide is independent of changes in circulating corticosteroids. Neuroimmunomodulation 4 : 188 – 194 Google Scholar PubMed WorldCat 13 Cunningham Jr ET , Sawchenko PE 1988 Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol 274 : 60 – 76 Google Scholar Crossref Search ADS PubMed WorldCat 14 Sawchenko PE , Li HY , Ericsson A 2000 Circuits and mechanisms governing hypothalamic responses to stress: a tale of two paradigms. Prog Brain Res 122 : 61 – 78 Google Scholar PubMed WorldCat 15 Fekete C , Wittmann G , Liposits Z , Lechan RM 2004 Origin of cocaine- and amphetamine-regulated transcript (CART)-immunoreactive innervation of the hypothalamic paraventricular nucleus. J Comp Neurol 469 : 340 – 350 Google Scholar Crossref Search ADS PubMed WorldCat 16 Marvel FA , Chen CC , Badr N , Gaykema RP , Goehler LE , Sagar SM , Price KJ , Kasting NW , Sharp FR 2004 Reversible inactivation of the dorsal vagal complex blocks lipopolysaccharide-induced social withdrawal and c-Fos expression in central autonomic nuclei. Anatomic patterns of Fos immunostaining in rat brain following systemic endotoxin administration. Brain Behav Immun 18 : 123 – 134 Google Scholar Crossref Search ADS PubMed WorldCat 17 Sagar SM , Price KJ , Kasting NW , Sharp FR 1995 Anatomic patterns of Fos immunostaining in rat brain following systemic endotoxin administration. Brain Res Bull 36 : 381 – 392 Google Scholar Crossref Search ADS PubMed WorldCat 18 Ericsson A , Kovacs KJ , Sawchenko PE 1994 A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J Neurosci 14 : 897 – 913 Google Scholar PubMed WorldCat 19 Takemura T , Makino S , Takao T , Asaba K , Suemaru S , Hashimoto K 1997 Hypothalamic-pituitary-adrenocortical responses to single vs. repeated endotoxin lipopolysaccharide administration in the rat. Brain Res 767 : 181 – 191 Google Scholar Crossref Search ADS PubMed WorldCat 20 Liposits Z , Paull WK , Wu P , Jackson IM , Lechan RM 1987 Hypophysiotrophic thyrotropin releasing hormone (TRH) synthesizing neurons. Ultrastructure, adrenergic innervation and putative transmitter action. Histochemistry 88 : 1 – 10 Google Scholar Crossref Search ADS PubMed WorldCat 21 Shioda S , Nakai Y , Sato A , Sunayama S , Shimoda Y 1986 Electron-microscopic cytochemistry of the catecholaminergic innervation of TRH neurons in the rat hypothalamus. Cell Tissue Res 245 : 247 – 252 Google Scholar Crossref Search ADS PubMed WorldCat 22 Fekete C , Kelly J , Mihály E , Sarkar S , Rand WM , Légrádi G , Emerson CH , Lechan RM 2001 Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary-thyroid axis. Endocrinology 142 : 2606 – 2613 Google Scholar PubMed WorldCat 23 Thompson RC , Seasholtz AF , Herbert E 1987 Rat corticotropin-releasing hormone gene: sequence and tissue-specific expression. Mol Endocrinol 1 : 363 – 370 Google Scholar Crossref Search ADS PubMed WorldCat 24 Kakucska I , Rand W , Lechan RM 1992 Thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is dependent upon feedback regulation by both triiodothyronine and thyroxine. Endocrinology 130 : 2845 – 2850 Google Scholar PubMed WorldCat 25 Kakucska I , Qi Y , Clark BD , Lechan RM 1993 Endotoxin-induced corticotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus is mediated centrally by interleukin-1. Endocrinology 133 : 815 – 821 Google Scholar PubMed WorldCat 26 McCann SM , Kimura M , Karanth S , Yu WH , Mastronardi CA , Rettori V 2000 The mechanism of action of cytokines to control the release of hypothalamic and pituitary hormones in infection. Ann NY Acad Sci 917 : 4 – 18 Google Scholar Crossref Search ADS PubMed WorldCat 27 Plotsky PM 1987 Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. Endocrinology 121 : 924 – 930 Google Scholar Crossref Search ADS PubMed WorldCat 28 Sarkar S , Wittmann G , Fekete C , Lechan RM 2004 Central administration of cocaine- and amphetamine-regulated transcript increases phosphorylation of cAMP response element binding protein in corticotropin-releasing hormone-producing neurons but not in prothyrotropin-releasing hormone-producing neurons in the hypothalamic paraventricular nucleus. Brain Res 999 : 181 – 192 Google Scholar Crossref Search ADS PubMed WorldCat 29 Vrang N , Larsen PJ , Kristensen P , Tang-Christensen M 2000 Central administration of cocaine-amphetamine-regulated transcript activates hypothalamic neuroendocrine neurons in the rat. Endocrinology 141 : 794 – 801 Google Scholar Crossref Search ADS PubMed WorldCat 30 Smith SM , Vaughan JM , Donaldson CJ , Rivier J , Li C , Chen A , Vale WW 2004 Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism. Endocrinology 145 : 5202 – 5209 Google Scholar Crossref Search ADS PubMed WorldCat 31 Wittmann G , Liposits Z , Lechan RM , Fekete C 2002 Medullary adrenergic neurons contribute to the neuropeptide Y-ergic innervation of hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in the rat. Neurosci Lett 324 : 69 – 73 Google Scholar Crossref Search ADS PubMed WorldCat 32 Hisano S , Fukui Y , Chikamori-Aoyama M , Aizawa T , Shibasaki T 1993 Reciprocal synaptic relations between CRF-immunoreactive- and TRH-immunoreactive neurons in the paraventricular nucleus of the rat hypothalamus. Brain Res 620 : 343 – 346 Google Scholar Crossref Search ADS PubMed WorldCat 33 Mitsuma T , Nogimori T , Hirooka Y 1987 Effects of growth hormone-releasing hormone and corticotropin-releasing hormone on the release of thyrotropin-releasing hormone from the rat hypothalamus in vitro. Exp Clin Endocrinol 90 : 365 – 368 Google Scholar Crossref Search ADS PubMed WorldCat 34 Masana MI , Heyes MP , Mefford IN 1990 Indomethacin prevents increased catecholamine turnover in rat brain following systemic endotoxin challenge. Prog Neuropsychopharmacol Biol Psychiatry 14 : 609 – 621 Google Scholar Crossref Search ADS PubMed WorldCat 35 Dun SL , Ng YK , Brailoiu GC , Ling EA , Dun NJ 2002 Cocaine- and amphetamine-regulated transcript peptide-immunoreactivity in adrenergic C1 neurons projecting to the intermediolateral cell column of the rat. J Chem Neuroanat 23 : 123 – 132 Google Scholar Crossref Search ADS PubMed WorldCat 36 Fekete C , Gereben B , Doleschall M , Harney JW , Dora JM , Bianco AC , Sarkar S , Liposits Z , Rand W , Emerson C , Kacskovics I , Larsen PR , Lechan RM 2004 Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus: implications for the nonthyroidal illness syndrome. Endocrinology 145 : 1649 – 1655 Google Scholar Crossref Search ADS PubMed WorldCat 37 Boelen A , Kwakkel J , Thijssen-Timmer DC , Alkemade A , Fliers E , Wiersinga WM 2004 Simultaneous changes in central and peripheral components of the hypothalamus-pituitary-thyroid axis in lipopolysaccharide-induced acute illness in mice. J Endocrinol 182 : 315 – 323 Google Scholar Crossref Search ADS PubMed WorldCat 38 Fekete C , Mihály E , Herscovici S , Salas J , Tu H , Larsen PR , Lechan RM 2000 DARPP-32 and CREB are present in type 2 iodothyronine deiodinase-producing tanycytes: implications for the regulation of type 2 deiodinase activity. Brain Res 862 : 154 – 161 Google Scholar Crossref Search ADS PubMed WorldCat 39 Tu HM , Kim SW , Salvatore D , Bartha T , Légrádi G , Larsen PR , Lechan RM 1997 Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology 138 : 3359 – 3368 Google Scholar PubMed WorldCat 40 Kakucska I , Qi Y , Lechan RM 1995 Changes in adrenal status affect hypothalamic thyrotropin-releasing hormone gene expression in parallel with corticotropin-releasing hormone. Endocrinology 136 : 2795 – 2802 Google Scholar PubMed WorldCat Copyright © 2005 by The Endocrine Society
TI - Ascending Brainstem Pathways Are Not Involved in Lipopolysaccharide-Induced Suppression of Thyrotropin-Releasing Hormone Gene Expression in the Hypothalamic Paraventricular Nucleus
JF - Endocrinology
DO - 10.1210/en.2004-1429
DA - 2005-03-01
UR - https://www.deepdyve.com/lp/oxford-university-press/ascending-brainstem-pathways-are-not-involved-in-lipopolysaccharide-0fS2ewMuWe
SP - 1357
VL - 146
IS - 3
DP - DeepDyve
ER -